The β-specific protein kinase C inhibitor ruboxistaurin (LY333531) suppresses glucose-induced adhesion of human monocytes to endothelial cells in vitro

Journal of Diabetes Science and Technology

Volumn 1, Issue 6, 2007, Pages 929-935

  Kunt, Thomas ^a   Forst, Thomas ^b   Kazda, Christof ^c   Harzer, Oliver ^d   Engelbach, Martin ^e   Löbig, Mirjam ^b   Beyer, Jürgen ^f   Pfützner, Andreas ^b,g  

^a Diabetes Practice   (Germany)

^b IKFE Institute for Clinical Research and Development   (Germany)

^c LILLY DEUTSCHLAND GMBH   (Germany)

^d Dr Reising Ackermann and Colleagues   (Germany)

^e Endocrinology Practice   (Germany)

^f UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^g UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Adhesion molecules; Endothelial dysfunction; Macrophage binding; Protein kinase C; Ruboxistaurin

Indexed keywords

EID: 84886719320     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680700100620     Document Type: Article

References (39)

1. Kikkawa R, Koya D, Haneda M. Progression of diabetic nephropathy. Am J Kidney Dis. 2003;41(Suppl 1):S19-21.
2. Setter SM, Campbell RK, Cahoon CJ. Biochemical pathways for microvascular complications of diabetes mellitus. Ann Pharmacother. 2003;37:1858-66.
3. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes. 1998;47:859-66.
4. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes. 1994;43:1122-9.
5. Derubertis FR, Craven PA. Activation of protein kinase C in glomerular cells in diabetes: mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes. 1994;43:1-8.
6. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI. High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol. 1991;261:F571-7.
7. Parker PJ, Murray-Rust J. PKC at a glance. J Cell Sci. 2004;117:131-2.
8. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J. 1998;332:281-92.
9. Ishii H, Koya D, King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med. 1998;76:21-31.
10. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA. 1992;89:11059-63.
11. Guo M, Wu MH, Korompai F, Yuan SY. Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. Physiol Genomics 2003;12:139-46.
12. Yuan SY. Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol. 2002;39:213-23.
13. Idris I, Gray S, Donnelly R. Protein kinase C activation: isozymespecific effects on metabolism and cardiovascular complications in diabetes. Diabetologia. 2001;44:659-73.
14. Natarajan R, Gonzales N, Xu L, Nadler JL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun. 1992;187:552-60.
15. Singh LP, Crook ED. Hexosamine regulation of glucose-mediated laminin synthesis in mesangial cells involves protein kinases A and C. Am J Physiol Renal Physiol. 2000;279:F646-54.
16. Chen S, Mukherjee S, Chakraborty C, Chakrabarti S. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am J Physiol Cell Physiol. 2003;284:C263-72.
17. Formisano P, Beguinot F. The role of protein kinase C isoforms in insulin action. J Endocrinol Invest. 2001;24:460-7.
18. Nesher R, Anteby E, Yedovizky M, War War N, Kaiser N, Cerasi E. Beta-cell protein kinases and the dynamics of the insulin response to glucose. Diabetes. 2002;51(Suppl 1):S68-73.
19. Gopalakrishna R, Jaken S. Protein kinase C signaling and oxidative stress. Free Radic Biol Med. 2000;28:1349-61.
20. Hoogerbrugge N, Verkerk A, Jacobs ML, Postema PT, Jongkind JF. Hypertriglyceridemia enhances monocyte binding to endothelial cells in NIDDM. Diabetes Care. 1996;19:1122-5.
21. Carantoni M, Abbasi F, Chu L, Chen YD, Reaven GM, Tsao PS, Varasteh B, Cooke JP. Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM. Diabetes Care. 1997;20:1462-5.
22. Kunt T, Forst T, Früh B, Flohr T, Schneider S, Harzer O, Pfutzner A, Engelbach M, Lobig M, Beyer J. Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro. Exp Clin Endocrinol Diabetes. 1999;107:252-6.
23. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA. 1989;86:5141-5.
24. Erratum in: Proc Natl Acad Sci USA. 1991 Nov. 1;88(21):9907.
25. Hill JR, Kwon G, Marshall CA, McDaniel ML. Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C. J Biol Chem. 1998;273:3308-13.
26. Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Zuodar G, Ceriello A. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis. 2005;183:259-67.
27. Kouroedov A, Eto M, Joch H, Volpe M, Luscher TF, Cosentino F. Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation. 2004;110:91-6.
28. Jaffe EA, Nachman RL, Becker CG Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-56.
29. King GL, Brownlee M. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am. 1993;25:255-70.
30. Studer RK, Craven PA, De Rubertis FR. Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes. 1993;42:118-26.
31. Xia P, Kramer RM, King GL. Identification of the mechanism for the inhibition of Na+, K (+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest. 1995;96:733-40.
32. King GL. The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes. Ann Med. 1996;28:427-32.
33. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Balias LM, Heath WF, Stramm LE, Feener EP, King GL. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science. 1996;72:728-31.
34. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest. 1997;100:115-26.
35. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788-91.
36. Kim JA, Berliner JA, Natarajan RD, Nadler JL. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes. 1994;43:1103-7.
37. Kunt T, Forst T, Wilhelm A, Tritschler H, Pfutzner A, Harzer O, Engelbach M, Zschaebitz A, Stofft E, Beyer J. Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products. Clin Sci (Lond). 1999;96:75-82.
38. Rojas S, Rojas R, Lamperti L, Casanello P, Sobrevia L. Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C, mitogen-activated protein kinases and nitric oxide in human umbilical vein endothelium. Exp Physiol. 2003;88:209-19.
39. Omiyi D, Brue RJ, Taormina P 2nd, Harvey M, Atkinson N, Young LH. Protein kinase C betall peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury. J Pharmacol Exp Ther. 2005;314:542-51.